Psychemedics Market Cap 2010-2024 | PMD

Psychemedics market cap history and chart from 2010 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Psychemedics market cap as of July 16, 2025 is $0B.
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.000B $0.020B
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $18.646B 18.38
Encompass Health (EHC) United States $11.080B 23.49
DaVita (DVA) United States $10.587B 14.89
Elanco Animal Health (ELAN) United States $7.206B 15.44
Chemed (CHE) United States $6.690B 21.02
Option Care Health (OPCH) United States $4.975B 22.18
RadNet (RDNT) United States $4.296B 272.67
Amedisys (AMED) United States $3.199B 21.52
Addus HomeCare (ADUS) United States $1.995B 21.91
LifeStance Health (LFST) United States $1.711B 0.00
Astrana Health (ASTH) United States $1.417B 35.11
U.S Physical Therapy (USPH) United States $1.120B 28.91
Pennant (PNTG) United States $0.819B 30.08
Aveanna Healthcare Holdings (AVAH) United States $0.778B 44.33
Atai Life Sciences (ATAI) Germany $0.541B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.039B 0.00
Ontrak (OTRK) United States $0.002B 0.00